Gabapentin and chronic cough

Gabapentin could be 'viable alternative' for chronic cough Gabapentin is a successful treatment for chronic cough and could be a 'viable'

A 63-y-old man with chronic cough and cough syncope was treated with low-dose gabapentin, a neuropathic pain medication, and showed significant improvement. The case report discusses the pathophysiology of cough syncope and the role of gabapentin in chronic cough.

Gabapentin resulted in a significant improvement in cough-specific quality of life, cough severity, and cough frequency and was well tolerated; therefore, it could be considered a viable alternative to current chronic cough treatment, especially for refractory chronic cough. The addition of gabapentin to chronic cough standard practice

Gabapentin treatment of patients with chronic Gabapentin versus baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough.

In patients with chronic cough, gabapentin led to improved cough symptoms compared with placebo.

Gabapentin: a suppressant for refractory chronic cough. Gabapentin: a suppressant for refractory chronic cough Lancet. 2024 Nov 3;380 (9853

Gabapentin is another agent that has been used to treat neuropathic pain and has been shown to be effective in reducing cough in chronic cough patients in a randomised double-blind trial, suggesting that there is a central reflex sensitisation in refractory chronic cough . Gabapentin was also beneficial in chronic cough patients with laryngeal

Chronic cough is neurological and it can be treated with gabapentin. A study also shows the effective treatment of Gabapentin for chronic

Gabapentin is another agent that has been used to treat neuropathic pain and has been shown to be effective in reducing cough in chronic cough patients in a randomised double-blind trial, suggesting that there is a central reflex sensitisation in refractory chronic cough . Gabapentin was also beneficial in chronic cough patients with laryngeal